Funding for this research was provided by:
National Natural Science Foundation of China (81903257, 81960534)
Natural Science Foundation of Guangxi Province (2020JJA140141)
National Major Science and Technology Projects of China (2017ZX10203207)
China International Medical Foundation-Tumor Precise Radiotherapy Spark Program (2019-N-11-01)
High-level innovation team and outstanding scholar program in Guangxi Colleges and Universities
Guangxi Medical University Training Program for Distinguished Young Scholars
Guangxi BaGui Scholars’ Special Fund.
Received: 30 December 2020
Accepted: 1 March 2021
First Online: 21 April 2021
: The study was approved by the Institutional Ethics Committee of Guangxi Medical University Cancer Hospital (LW2019038), and informed consent was waived because of the retrospective nature of this study.
: Not applicable.
: The authors declare no conflict of interest.